kabutan

TORAY INDUSTRIES,INC.(3402) Summary

3402
TSE Prime
TORAY INDUSTRIES,INC.
1,121.5
JPY
+4.0
(+0.36%)
Jan 29, 3:30 pm JST
7.33
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
1,126.5
Jan 29, 8:07 pm JST
Summary Chart Historical News Financial Result
PER
20.3
PBR
0.97
Yield
1.78%
Margin Trading Ratio
1.17
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
1,116.0 JPY 7.28 USD
Previous Close Jan 28
1,117.5 JPY 7.32 USD
High Jan 29, 3:12 pm
1,130.0 JPY 7.38 USD
Low Jan 29, 9:00 am
1,111.5 JPY 7.25 USD
Volume
4,032,900
Trading Value
4.52B JPY 0.03B USD
VWAP
1121.89 JPY 7.33 USD
Minimum Trading Value
112,150 JPY 733 USD
Market Cap
1.69T JPY 0.01T USD
Number of Trades
4,975
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
High
1-Year Average
7,999
1-Year High Feb 12, 2025
48,917
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 397,900 1,662,400 4.18
Jan 16, 2026 393,600 1,556,900 3.96
Jan 9, 2026 382,200 1,571,600 4.11
Dec 26, 2025 211,200 1,446,300 6.85
Dec 19, 2025 163,500 1,447,300 8.85
Company Profile
TORAY INDUSTRIES, INC. is the largest synthetic fiber manufacturer and a world leader in carbon fiber production. The company also operates in pharmaceuticals, electronic materials, and water treatment reverse osmosis membranes.
Sector
Texstiles & Apparels
TORAY INDUSTRIES, INC. is a comprehensive chemical manufacturer with business operations spanning various sectors including fibers and textiles, performance chemicals, carbon fiber composite materials, environment and engineering, and life sciences. In its fiber business, the company produces yarns, woven and knitted fabrics, non-woven fabrics, artificial leather, and apparel products made from materials such as nylon and polyester. The performance chemicals division manufactures resins, resin-molded products, films, and electronic and information materials. TORAY INDUSTRIES, INC. also engages in carbon fiber composite materials business, environment and engineering operations including functional membranes for water treatment, and life science ventures producing pharmaceuticals and medical devices. With numerous subsidiaries and affiliated companies worldwide, the company conducts business across a wide range of fields on a global scale.